Skip to content
akaturk Academic measurement
Sign in Sign up

Academician

SAFİYE ATLAS TÜLİN ERGUN

PROFESÖR

MARMARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Research topics OpenAlex
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Deri ve Zührevi Hastalıkları
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 108
YÖKSİS108 OpenAlex0
Projects 2
Books 2
Proceedings 16

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 90
h-index 30 Percentile in Türkiye: 100 #15 of 2,149 at their university by h-index
i10-index
56
Total citations
2,831
Top 0.9% in Türkiye
Per article
31.5
FWCI
1.93
1.00 = world average
World top 1%
1
World top 10%
17

Most cited articles

  1. Tofacitinib versus etanercept or placebo in moderate to severe chronic plaque psoriasis a phase 3 randomised non inferiority trial 2015 world top 1% 410 citations
  2. Serum leptin levels skin leptin and leptin receptor expression in psoriasis 2008 world top 10% 169 citations
  3. Oral health related quality of life is affected by disease activity in Behcet s disease 2006 world top 10% 164 citations

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Index quartiles

?
Scopus (SJR) 88
  • Q1 30 %34.1
  • Q2 42 %47.7
  • Q3 12 %13.6
  • Q4 4 %4.5
WoS (JCR) 88
  • Q1 24 %27.3
  • Q2 24 %27.3
  • Q3 25 %28.4
  • Q4 15 %17.0
TR Index 9 articles
OpenAlex citation percentile
Top 1%1
Top 10%18
Avg · n 97 %72.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 94

WoS (JCR)

  • YÖKSİS rows 94

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

108articles

Journals with publications

53 journals

Narrow down

Scopus (SJR)
Q130 Q242 Q312 Q44
WoS (JCR)
Q124 Q224 Q325 Q415
TR Index
9articles

Article list

  1. 2024 Human dental mesenchymal stem cells restorate immune response in sera of pemphigus vulgaris patients Archives of Dermatological Research DOI 10.1007/s00403-024-03358-6 YÖKSİS SJR Q1 JCR Q3 OpenAlex 22.3%
  2. 2024 Analysis of clinical characteristics and factors affecting treatment responses in patients with pyoderma gangrenosum: a multicenter study of 239 patients☆ Anais Brasileiros de Dermatologia DOI 10.1016/j.abd.2024.02.002 YÖKSİS SJR Q2 JCR Q1 OpenAlex 80.0%
  3. 2024 Disease burden, clinical management and unmet treatment need of patients with moderate to severe atopic dermatitis; consensus statements, insights and practices from CERTADE (Central/Eastern EU, Russia, Turkiye AD Experts) Delphi panel Frontiers in Medicine DOI 10.3389/fmed.2024.1402493 YÖKSİS SJR Q1 JCR Q1 OpenAlex 64.6%
  4. 2024 Disease burden, clinical management and unmet treatment need of patients with moderate to severe alopecia areata; consensus statements, insights, and practices from CERTAAE (Central/Eastern EU, Russia, Türkiye AA experts) Delphi panel Frontiers in Medicine DOI 10.3389/fmed.2024.1353354 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.2%
  5. 2024 Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients Dermatology and Therapy DOI 10.1007/s13555-024-01180-6 YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.2%
  6. 2024 Screening for familial disease presence in first-degree relatives of Behçet’s disease patients: Is measurement of common femoral vein wall thickness valuable for the diagnosis? Modern Rheumatology DOI 10.1093/mr/roae061 YÖKSİS SJR Q2 JCR Q3 OpenAlex 19.5%
  7. 2024 Clinical course of paediatric-onset Behçet’s disease in young adulthood Rheumatology DOI 10.1093/rheumatology/keae624 YÖKSİS SJR Q1 JCR Q1 OpenAlex 90.0%
  8. 2023 Evaluation of Arterial Stiffness Parameters and the Growth Differentiation Factor-15 Level in Patients with Premature Myocardial Infarction Journal of Personalized Medicine DOI 10.3390/jpm13101489 YÖKSİS SJR Q2 JCR Q1 OpenAlex 75.1%
  9. 2023 Earlier and more aggressive treatment with biologics may prevent relapses and further new organ involvement in Behçet's disease Clinical Immunology DOI 10.1016/j.clim.2023.109263 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 90.6%
  10. 2023 Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy Microvascular Research DOI 10.1016/j.mvr.2023.104591 YÖKSİS SJR Q2 JCR Q2 OpenAlex 60.9%
  11. 2023 Immunogenicity, efficacy, and safety of CoronaVac and Pfizer/BioNTech mRNA vaccines in patients with psoriasis receiving systemic therapies: A prospective cohort study Vaccine DOI 10.1016/j.vaccine.2023.05.052 YÖKSİS SJR Q1 JCR Q2 OpenAlex 60.3%
  12. 2023 Does decision tree analysis predict oral ulcer activity-related factors in patients with Behçets syndrome? Clinical and Experimental Rheumatology DOI 10.55563/clinexprheumatol/5kr2b1 YÖKSİS SJR Q2 JCR Q2 OpenAlex 62.2%
  13. 2023 Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B Turkish Journal of Gastroenterology DOI 10.5152/tjg.2022.22196 YÖKSİS SJR Q3 JCR Q4 OpenAlex 73.3%
  14. 2022 Drug eruption: A mimicker of Coronavirus disease-2019 rash TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY DOI 10.4274/turkerm.galenos.2021.29904 YÖKSİS TR Index SJR Q4 JCR Q4
  15. 2021 Mesenchymal stem cells derived from human dental follicle modulate the aberrant immune response in atopic dermatitis Immunotherapy DOI 10.2217/imt-2020-0257 2 YÖKSİS records YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.4%
  16. 2021 The assessment of presenteeism and activity impairment in Behçet\u2019s syndrome and recurrent aphthous stomatitis: a multicentre study Rheumatology DOI 10.1093/rheumatology/keab581 YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.7%
  17. 2021 Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease. Rheumatology (Oxford) DOI 10.1093/rheumatology/keaa264 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.9%
  18. 2021 The impact of antipsoriatic treatment on serum pro\u2010BDNF, BDNF levels, depression, anxiety scores, and quality of life Dermatologic Therapy DOI 10.1111/dth.14872 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.1%
  19. 2021 Secukinumab and infectious adverse effects: A real\u2010life experience of 63 psoriasis patients Australasian Journal of Dermatology DOI 10.1111/ajd.13588 YÖKSİS SJR Q2 JCR Q3 OpenAlex 51.4%
  20. 2021 Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa Cytokine DOI 10.1016/j.cyto.2021.155585 YÖKSİS SJR Q2 JCR Q3 OpenAlex 89.0%

← Back to academicians